Contribution: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
AgGene Inc.
$242,920.00
Development of high protein chickpea (Cicer arietinum) variety using advanced plant breeding techniques.
FY 2023-24 · 2024-01-08
Summary
The development of high protein crop varieties is a critical process to meet the future demand for dietary protein. Chickpea is an important commodity in the plant protein sector, which would benefit from advanced plant breeding techniques including genome editing. This project focuses on the development of high protein chickpea varieties using genome editing. Genome editing can be utilized to enhance the production and accumulation of seed protein, which would add value to seed processors and food ingredient manufacturers. AgGene has identified a set of candidate genes that can be disrupted and modulated to increase seed protein content through genome editing. This project will help establish genome editing practices to help expedite the development of new traits and technologies that can increase competitiveness and value of chickpea commodities.
Department
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
792522740
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-01-08 | 2023-24 | $199,600.00 |
| 1 | 2024-01-08 | 2023-24 | $242,920.00 |
As published
Additional Information
This agreement has been amended 1 time(s) the total amended value is $242,920.The end date of this agreement has been modified by 58 days.
Additional Information (French)
Cet accord a été modifié 1 fois la valeur totale des modifications est de 242,920$. La date de fin du présent accord a été changé de 58 jours.
Agreement End Date
2026-03-30
Agreement Number
1011864
Agreement Start Date
2024-01-08
Agreement Title
Development of high protein chickpea (Cicer arietinum) variety using advanced plant breeding techniques.
Agreement Title (French)
Mise au point d’une variété de pois chiches (Cicer arietinum) à haute teneur en protéines à l’aide de techniques avancées de sélection végétale
Agreement Type
Contribution
Agreement Value
$242,920.00
Amendment Date
2025-04-14
Amendment Number
1
Description
The development of high protein crop varieties is a critical process to meet the future demand for dietary protein. Chickpea is an important commodity in the plant protein sector, which would benefit from advanced plant breeding techniques including genome editing. This project focuses on the development of high protein chickpea varieties using genome editing. Genome editing can be utilized to enhance the production and accumulation of seed protein, which would add value to seed processors and food ingredient manufacturers. AgGene has identified a set of candidate genes that can be disrupted and modulated to increase seed protein content through genome editing. This project will help establish genome editing practices to help expedite the development of new traits and technologies that can increase competitiveness and value of chickpea commodities.
Description (French)
La mise au point de variétés de cultures à haute teneur en protéines est essentielle pour répondre à la demande future de protéines alimentaires. Le pois chiche est une denrée importante dans le secteur des protéines végétales qui bénéficierait de techniques avancées de sélection végétale, y compris l’édition génomique. Ce projet met l’accent sur la mise au point de variétés de pois chiches à haute teneur en protéines fondée sur l’édition génomique pour améliorer la production et l’accumulation de protéines séminales, et ainsi apporter une valeur ajoutée aux transformateurs de semences et aux fabricants d’ingrédients alimentaires. AgGene a recensé un ensemble de gènes candidats qui peuvent être perturbés et modulés pour augmenter la teneur en protéines des graines grâce à l’édition génomique. Ce projet permettra d’établir des pratiques d’édition génomique capables d’accélérer la mise au point de nouvelles caractéristiques et technologies ouvrant la voie à des produits à base de pois chiches concurrentiels de grande valeur.
Expected Results
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Expected Results (French)
À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Name (French)
Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
Program Purpose
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
Program Purpose (French)
Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
Recipient Business Number
792522740
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
AgGene Inc.
Recipient Postal Code
T2L 1Y8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2023-2024-Q4-1011864